MaineLD 697132nd Maine Legislature (2025-2026)Senate

An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing

Sponsored By: Cameron D. Reny (Democratic)

Became Law

PRESCRIPTION DRUGSPRESCRIPTION DRUGS - AFFORDABILITY BOARD

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

3 provisions identified: 1 benefits, 1 costs, 1 mixed.

Maine must plan for lower drug costs

Maine’s Prescription Drug Affordability Board must study ways to lower drug costs and patients’ out-of-pocket spending. It must review spending and use data, seek public input, and consult its advisory council and any technical committees. Required studies cover upper payment limits and reference pricing, which uses benchmark prices. The reference-pricing review includes state employee health plan savings on the first 10 drugs negotiated through Medicare’s drug price negotiation program. Other required studies cover public and commercial insurance spending targets, drug supply-chain oversight, and disclosure of discounts and rebates. The board must also study insurance rules and rate reviews to lower patient costs, provider education, and payments tied to actual drug purchase costs. It must weigh effects on consumers and total health costs, practical barriers, and other states’ experience. A preliminary program plan is due January 30, 2026, and a final plan is due October 1, 2027. Plans must identify implementation and enforcement steps, needed funding and authority, and needed legislative changes. These requirements do not themselves set drug prices or guarantee household savings.

One board member loses expense payments

The Maine Health Data Organization director or designee cannot receive legislative daily pay or expense reimbursement for board service. This exclusion applies to service on the Prescription Drug Affordability Board. Other board members and the specified advisory council member remain eligible for these payments.

Maine funds drug affordability board staff

Beginning October 1, 2025, the Office of Affordable Health Care receives funding for one Public Service Manager III position. The manager supports the drug affordability board’s planning, government and stakeholder relations, research, writing, and administrative work. The law appropriates $107,817 for fiscal year 2025-26 and $149,118 for fiscal year 2026-27. This public spending supports affordability work but does not directly lower drug prices or provide household payments.

Sponsors & Cosponsors

Sponsor

  • Cameron D. Reny

    Democratic • Senate

Cosponsors

  • Anne-Marie Mastraccio

    Democratic • House

  • Denise Tepler

    Democratic • Senate

  • Donna Bailey

    Democratic • Senate

  • Henry L. Ingwersen

    Democratic • Senate

  • Joseph Rafferty

    Democratic • Senate

  • Kristi Mathieson

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 160 • No: 9

House vote • 6/2/2025

ACC MAJ OTP AS AMENDED REP

Yes: 125 • No: 9

Senate vote • 5/29/2025

ACCEPT MAJORITY OUGHT TO PASS AS AMENDED REPORT

Yes: 35 • No: 0

Actions Timeline

  1. ACTPUB Chapter 530

    1/11/2026
  2. HELD BY THE GOVERNOR.

    7/8/2025Senate
  3. PASSED TO BE ENACTED, in concurrence.

    6/25/2025Senate
  4. PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.

    6/25/2025House
  5. The House RECEDED and CONCURRED to PASSAGE TO BE ENGROSSED as Amended by Committee Amendment "A" (S-159) as Amended by Senate Amendment "A" (S-459) thereto.ORDERED SENT FORTHWITH.

    6/25/2025House
  6. On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table On motion by Same Senator the Senate SUSPENDED THE RULES to RECONSIDER their actions whereby the Bill was PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (S-159) On further motion by Same Senator the Senate SUSPENDED THE RULES to RECONSIDER their actions whereby Committee Amendment "A" (S-159) was ADOPTED. On further motion by Same Senator Senate Amendment "A" (S-459) to Committee Amendment "A" (S-159) READ and ADOPTED. Committee Amendment "A" (S-159) as Amended by Senate Amendment "A" (S-459) thereto ADOPTED. PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (S-159) as Amended by Senate Amendment "A" (S-459) thereto in NON-CONCURRENCE. Sent down for concurrence.

    6/25/2025Senate
  7. On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence

    6/2/2025Senate
  8. PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.

    6/2/2025House
  9. Reports READ.On motion of Representative MATHIESON of Kittery, the Majority Ought to Pass as Amended Report was ACCEPTED.ROLL CALL NO. 249(Yeas 125 - Nays 9 - Absent 17 - Excused 0)The Bill was READ ONCE.Committee Amendment "A" (S-159) was READ and ADOPTED.Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (S-159). In concurrence. ORDERED SENT FORTHWITH.

    6/2/2025House
  10. Taken from the table by the President On motion by Senator BAILEY of York The Majority Ought to Pass As Amended Report ACCEPTED. PREVAILED Roll Call Ordered Roll Call Number 269 Yeas 35 - Nays 0 - Excused 0 - Absent 0 Bill READ ONCE Committee Amendment "A" (S-159) READ and ADOPTED Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (S-159) Sent down for concurrence

    5/29/2025Senate
  11. Reports READ On motion by Senator BAILEY of York Tabled until Later in Today's Session, pending ACCEPTANCE OF EITHER REPORT. Unfinished Business

    5/28/2025Senate
  12. CARRIED OVER, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.

    3/21/2025Senate
  13. Received by the Secretary of the Senate on February 20, 2025 and REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2

    2/20/2025Senate

Bill Text

  • Amendment C-A (S-159), adopted by House & Senate

  • Amendment S-A to C-A (S-459), adopted by House & Senate

  • Enacted

  • Introduced

Related Bills

Back to State Legislation